Skip to main content
Top
Published in: Indian Journal of Pediatrics 5/2019

01-05-2019 | Neuroblastoma | Editorial Commentary

Neuroblastoma in a Developing Country: Miles to Go

Authors: Jagdish Prasad Meena, Aditya Kumar Gupta

Published in: Indian Journal of Pediatrics | Issue 5/2019

Login to get access

Excerpt

Neuroblastoma (NB) is the most common intraabdominal and extracranial solid tumor in children, accounting for approximately 8% to 10% of all childhood malignancies. As per the ‘Indian Council of Medical Research (ICMR), National Cancer Registry Program’, the relative proportion of NB (and ganglioneuroblastoma) in children (0–14 y), in seven hospital-based cancer registries across India varied from 2.4% to 7.5%. Neuroblastoma is the most common malignancy diagnosed during infancy. It can arise from anywhere along the sympathetic chain and usually presents as a mass arising in the neck, mediastinum, abdomen or pelvis. Neuroblastoma is a disease of early childhood with approximately 90% of patients presenting before the age of five years. In infants, these tumors may regress spontaneously, or they may mature into a benign ganglioneuroma. Neuroblastoma in older children is usually unresectable or is metastatic at presentation, and the overall prognosis is poor [1, 2]. …
Literature
1.
go back to reference Brodeur GM, Hogarty MD, Mosse YP, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams and Wilkins; 2016. p. 772–97. Brodeur GM, Hogarty MD, Mosse YP, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams and Wilkins; 2016. p. 772–97.
3.
go back to reference Kitonyi GW, Macharia WM, Mwanda OW, Pamnani R. Clinico-pathologic characteristics and treatment outcomes in children with neuroblastoma at the Kenyatta National Hospital. Nairobi East Afr Med J. 2009;86:S39–46.PubMed Kitonyi GW, Macharia WM, Mwanda OW, Pamnani R. Clinico-pathologic characteristics and treatment outcomes in children with neuroblastoma at the Kenyatta National Hospital. Nairobi East Afr Med J. 2009;86:S39–46.PubMed
4.
go back to reference Hesseling PB, Ankone K, Wessels G, Schneider JW, Plessis D, Moore L. Neuroblastoma in southern Africa: epidemiological features, prognostic factors and outcome. Ann Trop Paediatr. 1999;19:357–63.CrossRefPubMed Hesseling PB, Ankone K, Wessels G, Schneider JW, Plessis D, Moore L. Neuroblastoma in southern Africa: epidemiological features, prognostic factors and outcome. Ann Trop Paediatr. 1999;19:357–63.CrossRefPubMed
5.
go back to reference Parise IZ, Haddad BR, Cavalli LR, et al. Neuroblastoma in southern Brazil: an 11-year study. J Pediatr Hematol Oncol. 2006;28:82–7.CrossRefPubMed Parise IZ, Haddad BR, Cavalli LR, et al. Neuroblastoma in southern Brazil: an 11-year study. J Pediatr Hematol Oncol. 2006;28:82–7.CrossRefPubMed
6.
go back to reference Li K, Dong K, Gao J. YaoW, Xiao X, Zheng S. Neuroblastoma management in Chinese children. J Investig Surg. 2012;25:86–92.CrossRef Li K, Dong K, Gao J. YaoW, Xiao X, Zheng S. Neuroblastoma management in Chinese children. J Investig Surg. 2012;25:86–92.CrossRef
7.
go back to reference Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010;24:65–86.CrossRefPubMed Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010;24:65–86.CrossRefPubMed
8.
go back to reference Erdelyi DJ, Elliott M, Phillips B. Urine catecholamines in paediatrics. Arch Dis Child Educ Pract Ed. 2011;96:107–11.CrossRefPubMed Erdelyi DJ, Elliott M, Phillips B. Urine catecholamines in paediatrics. Arch Dis Child Educ Pract Ed. 2011;96:107–11.CrossRefPubMed
9.
go back to reference Matthay KK, Edeline V, Lumbroso J, et al. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol. 2003;21:2486–91.CrossRefPubMed Matthay KK, Edeline V, Lumbroso J, et al. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol. 2003;21:2486–91.CrossRefPubMed
10.
go back to reference Kushner BH, Yeung HW, Larson SM, et al. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. J Clin Oncol. 2001;19:3397–405.CrossRefPubMed Kushner BH, Yeung HW, Larson SM, et al. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. J Clin Oncol. 2001;19:3397–405.CrossRefPubMed
11.
go back to reference Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med. 2004;29:86–90.CrossRefPubMed Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med. 2004;29:86–90.CrossRefPubMed
12.
go back to reference Parikh NS, Howard SC, Chantada G, et al. SIOP-PODC adapted risk stratification and treatment guidelines: recommendations for neuroblastoma in low- and middle-income settings. Pediatr Blood Cancer. 2015;62:1305–16.CrossRefPubMedPubMedCentral Parikh NS, Howard SC, Chantada G, et al. SIOP-PODC adapted risk stratification and treatment guidelines: recommendations for neuroblastoma in low- and middle-income settings. Pediatr Blood Cancer. 2015;62:1305–16.CrossRefPubMedPubMedCentral
13.
go back to reference Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with conventional chemotherapy in children older than one year: a 15 y experience. Indian Pediatr. 2008;45:135–9.PubMed Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with conventional chemotherapy in children older than one year: a 15 y experience. Indian Pediatr. 2008;45:135–9.PubMed
14.
go back to reference Agarwala S, Mandelia A, Bakhshi S, et al. Neuroblastoma: outcome over a 14 y period from a tertiary care referral centre in India. J Pediatr Surg. 2014;49:1280–5.CrossRefPubMed Agarwala S, Mandelia A, Bakhshi S, et al. Neuroblastoma: outcome over a 14 y period from a tertiary care referral centre in India. J Pediatr Surg. 2014;49:1280–5.CrossRefPubMed
15.
go back to reference Kusumakumari P, Ajithkumar TV, Hariharan S, et al. Intensive chemotherapy in children with stage IV neuroblastoma. Indian J Pediatr. 1999;66:867–72.CrossRefPubMed Kusumakumari P, Ajithkumar TV, Hariharan S, et al. Intensive chemotherapy in children with stage IV neuroblastoma. Indian J Pediatr. 1999;66:867–72.CrossRefPubMed
16.
Metadata
Title
Neuroblastoma in a Developing Country: Miles to Go
Authors
Jagdish Prasad Meena
Aditya Kumar Gupta
Publication date
01-05-2019
Publisher
Springer India
Published in
Indian Journal of Pediatrics / Issue 5/2019
Print ISSN: 0019-5456
Electronic ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-019-02930-7

Other articles of this Issue 5/2019

Indian Journal of Pediatrics 5/2019 Go to the issue